Oleandomycin, a 14-member ring macrolide, has an antibacterial spectrum similar to that of erythromycin but is less active in vitro. However, oleandomycin has much greater acid stability than erythromycin base. Because of this key advantage, chemical modification of oleandomycin was initiated in an attempt to increase potency (1) . It was found that the substitution of a nitrogen functionality for the C"-4 hydroxyl conferred increased antibacterial potency in the derivatives. A comparison of the in vitro and in vivo activities of these derivatives with the activities of oleandomycin and erythromycin is reported here.
MATERIALS AND METHODS
Antibiotics and chemicals. The three derivatives and oleandomycin were prepared by members of the Department of Medicinal Chemistry in the Central Research Division, Pfizer Inc., Groton, Conn., by previously described methods (1) . Erythromycin was purchased from commercial sources. All compounds were used as the free base. The oleandomycin derivatives were unique in that the C"-4 hydroxyl moiety was replaced with a nitrogen functionality, i.e., p-chlorobenzene-sulfonamide (P-CBS), 3-methyl-thiophene-sulfonamide , or thiophene-sulfonamide (TPS) (Fig. 1 infusion agar slants or appropriately adjuncted brain heart infusion agar slants were inoculated, and the resulting growth was layered with sterile mineral oil. These were maintained at refrigerator temperature until used.
MICs. Minimal inhibitory concentrations (MICs) were determined by a standard dilution method as described previously (7) . The basal medium, brain heart infusion agar, was enriched with 5% (vol/vol) sheep 5 min, at which time they were removed, allowed to cool, and then put on ice water for 1 h. Precipitated protein was removed by filtering through a type BD 0.6-,um Polyvic Millipore filter prewashed with 3 ml of the above 5% solution. The filters were then washed three times with 3 ml of ice-cold 5% trichloroacetic acid solution, removed from holders, allowed to air dry, and placed in scintillation vials. 2-Methoxyethanol (1 ml) and 3A70 counting cocktail (5 ml) were added to each vial, and radioactivity was counted.
RESULTS The MICs of the experimental macrolides P-CBS, 3-MeTPS, and TPS for 90% of erythromycin-susceptible Staphylococcus aureus isolates ranged from 0.2 to 0.39 ,ug/ml; this was one-half to one-eighth the corresponding MICs for erythromycin and the parent compound, oleandomycin. The 50% MICs (MIC50s) of the experimental macrolides for S. aureus isolates resistant to erythromycin ranged from 0.2 to 0.39 ,ug/ml, compared with MIC50s of 12.5 ,ug/ml for erythromycin and 1.6 ,ug/ml for oleandomycin ( Table 1) .
The MIC50s of P-CBS, 3-MeTPS, and TPS for clinical isolates of Staphylococcus epidermidis were equivalent to those of erythromycin. Erythromycin had the lowest MIC50 against Streptococcus faecalis and, except for P-CBS, was the most active compound against S. pyogenes and Streptococcus viridans (Table 1) .
The activities of the experimental compounds against clinical isolates of H. influenzae and B. fragilis (Table 1) were equivalent to those of erythromycin and were markedly superior to those of oleandomycin. Although the MICs of the experimental compounds against Escherichia coli isolates were not within a clinically useful range, these agents were four times as active as erythromycin (Table 1) .
Derivatives P-CBS and 3-MeTPS had identical oral activities against the experimental infection produced by the susceptible S. aureus strains in mice (Table 2) . Based on PD50s, both were twice as active as TPS and more than three times as active as erythromycin base. P-CBS was two to three times more active than 3-MeTPS and TPS against infections produced by erythromycin-resistant S. aureus; erythromycin was inactive against this organism at a dosage of 220 mg/kg.
Based on PD50s against experimental S. pyogenes infection, 3-MeTPS was five to nine times more active than TPS, P-CBS, and erythromycin (Table 2) .
TPS, P-CBS, and 3-MeTPS were equally active in inhibiting MS2 viral RNA-directed polypeptide synthesis in E. coli cell extracts (Fig. 2) . At a concentration of 0.3 FtM, polypeptide synthesis was inhibited about 90% by the experimental macrolides. Erythromycin effected about 50% inhibition, and oleandomycin effected about 26% inhibition, at this concentration.
DISCUSSION
The rank-order relationship between MICs and in vivo activities of the experimental macrolides in the infections produced by the erythromycin-susceptible and erythromycin-resistant S. aureus was good (Table 2) . P-CBS, for example, had the lowest MIC against erythromycin-resistant S. aureus and demonstrated the lowest PD50. The MICs and PD50s of 3-MeTPS and TPS were two to four times greater than those of P-CBS against this resistant S. aureus.
Given the improved activity of these new derivatives against E. coli (Table 1) , we sought to identify a mechanistic basis for the distinction from erythromycin and oleandomycin. It has been known for several years that the weak activity shown by erythromycin against the Enterobacteriaceae results from poor penetration of the outer cell wall. The erythromycin molecule is too large to pass easily through the porins (5, 8) . When tested against L-forms, i.e., cells lacking a cell wall, erythromycin demonstrated excellent activity (9) . Because P-CBS, 3-MeTPS, and TPS have greater molecular weights than oleandomycin and erythromycin, they should also be too large to penetrate the E. coli outer cell wall readily. It has been demonstrated that erythromycin binds to the 50S subunits of S. aureus and E. coli ribosomes with equal affinity (4, 10) . Thus, by measuring the ability of 14-member ring macrolides to inhibit protein synthesis in a cell extract obtained from E. coli, we sought to discriminate between increased intrinsic efficacy and an effect of the molecular modifications on increased transport.
The data presented in Fig. 2 indicate that the experimental macrolides are much more active than erythromycin and oleandomycin in the cell-free system. This suggests that their greater potency against intact cells as compared with the parent oleandomycin compound is probably due to their superior ability to interact with the ribosome. Interestingly, the concentration of the oleandomycin derivatives required to inhibit polypeptide synthesis (0.26 ,ug/ml; Fig. 2 ) is very similar to the concentration required to inhibit susceptible S. aureus (Table 1) .
The above studies indicate that both biological and chemical properties of oleandomycin, e.g., increased potency and increased affinity for the ribosome, can be profoundly altered by chemical replacement of the C"-4 hydroxyl group of the oleandrose sugar with various nitrogen functionalities.
